ST. PAUL, Minn. Spineology Inc., the innovator in anatomy-conserving surgery™, is pleased to announce that Hermed Capital, a private equity fund located in Shanghai, China, has made a $5 million investment in the form of a convertible debenture. The proceeds from this financing are expected to fund additional commercialization, product development, and clinical research efforts for the company. "We believe the Spineology investment is a very exciting opportunity," stated Dr. Jerry Xiao, Managing Director of Hermed Capital. "Spineology possess a very novel product portfolio in an otherwise very homogeneous market. We look forward to working with them as they grow...